Julian Bowen Consort Dining Table, Honey, Height: 77, Width: 92, Depth: 92cm

£9.9
FREE Shipping

Julian Bowen Consort Dining Table, Honey, Height: 77, Width: 92, Depth: 92cm

Julian Bowen Consort Dining Table, Honey, Height: 77, Width: 92, Depth: 92cm

RRP: £99
Price: £9.9
£9.9 FREE Shipping

In stock

We accept the following payment methods

Description

Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637–9. Departments of Pediatrics and Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303(20):2058–64.

Guidelines for Reporting Outcomes in Trial Reports: The

Boutron I, Altman D, Moher D, Schulz KF, Ravaud P. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7. Mayo-Wilson E, Fusco N, Li T, et al. Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis. J Clin Epidemiol. 2017;86:39–50. Li T, Hutfless S, Scharfstein DO, et al. Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus. J Clin Epidemiol. 2014;67(1):15–32. Grant SP, Mayo-Wilson E, Melendez-Torres GJ, Montgomery P. Reporting quality of social and psychological intervention trials: a systematic review of reporting guidelines and trial publications. PLoS One. 2013;8(5):e65442. Moher D, Hopewell S, Schultz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.CONSORT Abstracts: Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schulz KF, the CONSORT Group. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008; 5(1):e20. PMID: 18215107

CONSORT 2010 Explanation and Elaboration: updated - The BMJ

SG, EMW, and PM conceived of the idea for the project and contributed equally to this manuscript. SG, EMW, PM, GM, SM, SH, and DM led the project and wrote the first draft of the manuscript. All authors have contributed to and approved the final manuscript. Corresponding authorThe dates of a trial and its activities provide readers some information about the historical context of the trial [ 48]. The SPIRIT 2013 Statement includes a table that authors can use to provide a complete schedule of trial activities, including recruitment practices, pre-randomisation assessments, periods of intervention delivery, a schedule of post-randomisation assessments, and when the trial was stopped [ 55]. In the description, authors should define baseline assessment and follow-up times relative to randomisation. For example, by itself, ‘4-week follow-up’ is unclear and could mean different things if meant after randomisation or after the end of an intervention. Item 14b: why the trial ended or was stopped CONSORT Cluster: Campbell MK, Piaggio G, Elbourne DR, Altman DG; CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661. PMID: 22951546

Consolidated Standards of Reporting Trials - Wikipedia

The CONSORT (Consolidated Standards of Reporting Trials) Statement was developed to help authors report randomised controlled trials (RCTs) [ 1]. It has improved the quality of reports in medicine [ 2, 3, 4, 5], and has been officially endorsed by over 600 journals and prominent editorial groups [ 6]. A smaller number of journals have implemented CONSORT—particularly its extension statements—as a requirement for the manuscript submission, peer-review, and editorial decision-making process [ 6, 7]. There are extensions of the CONSORT Statement ( http://www.consort-statement.org/extensions) for specific trial designs [ 8, 9, 10, 11], types of data (e.g. patient-reported outcomes, harms, and information in abstracts) [ 12, 13, 14], and interventions [ 15, 16, 17]. Chalmers I. Trying to do more good than harm in policy and practice: the role of rigorous, transparent, up-to-date evaluations. Ann Am Acad Polit Soc Sci. 2003;589(22):22–40. CONSORT 2010 has been translated into the following languages: Chinese; French; German; Greek; Italian; Japanese; Persian; Polish; Portuguese; Russian; Spanish; Turkish. Fraser MW, Galinsky MJ, Richman JM, Day SH. Intervention research: developing social programs. New York: Oxford University Press; 2009. McCord J. Cures that harm: unanticipated outcomes of crime prevention programs. Ann Am Acad Polit Soc Sci. 2003;587:16–30.Fernández-Hernando D, Justribó Manion C, Pareja JA, García-Esteo FJ, Mesa-Jiménez JA. Fernández-Hernando D, et al. J Clin Med. 2023 Sep 30;12(19):6315. doi: 10.3390/jcm12196315. J Clin Med. 2023. PMID: 37834959 Free PMC article. Review. Behavioral & Policy Sciences, RAND Corporation, 1776 Main Street, Santa Monica, CA, 90407-2138, USA Simmons JP, Nelson LD, Simonsohn U. False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci. 2011;22(11):1359–66. Wilson DB. Comment on ‘developing a reporting guideline for social and psychological intervention trials’. J Exp Criminol. 2013;9:375–7.



  • Fruugo ID: 258392218-563234582
  • EAN: 764486781913
  • Sold by: Fruugo

Delivery & Returns

Fruugo

Address: UK
All products: Visit Fruugo Shop